SRPT
Sarepta Therapeutics, Inc. · Healthcare
Director Michael Andrew Chambers bought $1.1M of Sarepta Therapeutics, Inc.
Bought$1,092,429
$109.47Price
9,979Shares
+4%Stake
What SRPT did for a copier
- $1,000 copied at Tue, Aug 15 open, $112.75
- $1,095
- S&P 500, same days
- −4.2%
Measured over 30 trading days, to the Sep 27 close.
Michael Andrew Chambers's record
4 other buys with 3 months of prices since 2022: on average −7.0% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Aug 14. Filed Tue, Aug 15, 8:00 AM ET, before the open. Returns use the Aug 15 open and the Sep 27 close. Not investment advice.